Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Stroke. 2018 Jun 18;49(7):1678–1685. doi: 10.1161/STROKEAHA.118.020553

Figure 1.

Figure 1

Kaplan-Meier curves for the primary endpoint (time to stroke, myocardial infarction, or death) in patients randomized to the aspirin or ticagrelor groups with or without taking aspirin prior to randomization: a) full 90-day treatment period; b) censored at 7 days.

bd, twice daily; CI, confidence interval; HR, hazard ratio; and od, once daily.